Rhon Pal Biotech Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
- Paid Up Capital ₹ 0.10 M
- Company Age 21 Year, 8 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth 0.19%
- Profit Growth -49.76%
- Ebitda 135.04%
- Net Worth 21.72%
- Total Assets 26.43%
About Rhon Pal Biotech
Rhon Pal Biotech Private Limited. (RPBPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 11 June 2003 and has a history of 21 years and eight months. Its registered office is in Delhi, India.
The Company is engaged in the Musical Instruments Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Santosh Tiwari, Brij Sharma, and Rahul Mishra serve as directors at the Company.
Company Details
- Location
Delhi, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24239DL2003PTC120867
- Company No.
120867
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
11 Jun 2003
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Who are the key members and board of directors at Rhon Pal Biotech?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Santosh Tiwari  | Director | 10-Feb-2022 | Current |
| Brij Sharma | Director | 28-Jun-2024 | Current |
| Rahul Mishra | Director | 03-Oct-2019 | Current |
Financial Performance of Rhon Pal Biotech.
Rhon Pal Biotech Private Limited., for the financial year ended 2017, experienced modest growth in revenue, with a 0.19% increase. The company also saw a substantial fall in profitability, with a 49.76% decrease in profit. The company's net worth Soared by an impressive increase of 21.72%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Rhon Pal Biotech?
In 2017, Rhon Pal Biotech had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Vee Envsol Private LimitedRahul Mishra is a mutual person
- Paladin Green Technologies Private Limited
Rahul Mishra is a mutual person
- Level One India Distributors Private Limited
Rahul Mishra is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Rhon Pal Biotech?
Unlock and access historical data on people associated with Rhon Pal Biotech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Rhon Pal Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Rhon Pal Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
